Key Highlights

  • Jeff Hanson has been named Chief Executive Officer following Danny Prosky's retirement.
  • Gabe Willhite has been elevated to President with a new cash compensation of $100,000.
  • Scott Estes appointed Lead Independent Director, enhancing corporate governance.
  • The changes are expected to strengthen American Healthcare REIT's strategic direction in the senior housing sector.

American Healthcare REIT, Inc. is undergoing significant leadership changes, marking a new chapter as Jeff Hanson steps in as Chief Executive Officer. Following the retirement of Danny Prosky, who has served in executive roles since the company's founding, these appointments are set to recalibrate the company’s strategic focus toward growth and shareholder value, as highlighted by Hanson's previous role as Chairman. Hanson believes the company is positioned for substantial growth, further supported by his extensive experience and familiarity with the operational intricacies of American Healthcare REIT.

Transition Details

The company officially announced the leadership transitions effective July 21, 2026. Jeff Hanson, who had been Interim CEO since February, has now been named CEO while retaining his position as Chairman. Alongside him, Gabe Willhite has been promoted to President while continuing as Chief Operating Officer.

This restructuring takes place as Prosky, despite retiring from executive duties, will retain a role on the Board of Directors and contribute as an advisor. This leadership change could enhance operational agility and strategic responsiveness in a competitive real estate market focused on healthcare. These adjustments signal a carefully crafted plan to continue growth momentum in the senior housing sector.

Compensation Mechanics

As part of his new role, Hanson will receive an annual base salary of $965,000, along with a target annual bonus opportunity of 160% of his base salary. He is also set to receive time-based restricted stock units valued at $2,072,534, vesting in three equal installments over the subsequent three years. Willhite will benefit from a $100,000 salary increase and a boost in his target cash bonus to 125% of his annual compensation.

The strategic alignment around compensation packages appears designed to incentivize performance and commitment to the company's goals. This structured approach positions the leadership team for potential long-term growth as they tackle the challenges in the healthcare real estate investment market.

Implications for Growth

These leadership changes come at a important time for American Healthcare REIT as it navigates a transformative period in the senior housing market. With Willhite harnessing nearly a decade of experience within the company, his elevation to President can be seen as a strategic move to solidify operational effectiveness amid growing sector opportunities. As the focus shifts toward scaling operations and capturing market share, the board’s decision highlights its commitment to operational excellence.

By leveraging their established leadership depth, American Healthcare REIT aims to drive innovative strategies that align with evolving market demands, ultimately enhancing value for shareholders.

Upcoming Catalysts

Following these appointments, investors should monitor how the new leadership will address upcoming opportunities in the senior housing sector. One key date to watch will be the company’s earnings release in the following quarter, which will provide insights into initial impacts driven by the leadership changes. With a market environment that is increasingly favorable for senior housing investments, providing strong quarterly results will be key in shaping investor sentiment and confirming the board’s confidence in the new leadership team.

Stakeholders will be keenly interested in the articulation of business strategies that emerge from this transition in leadership.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.